Medications for Treating Alzheimer’s Dementia
The Carlat Psychiatry Report, Volume 8, Number 4, April 2010
https://www.thecarlatreport.com/newsletter-issue/tcprv8n4/
Issue Links: Learning Objectives | Editorial Information
Topics: Dementia
Dhwani Shah, MD
While drug companies have been working hard to come up with new options for the treatment of dementia, there have been no new FDA approvals since memantine (Namenda) hit the scene in 2003.
You can't view details of this content, please login or buy subscription here
Dhwani Shah, MD
Associate Clinical Faculty Member University of Pennsylvania
Dr. Shah has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.